VAM
RIGL icon

Visium Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Visium Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,200
Closed -$30K – 809
2015
Q3 		$30K Sell
1,200
-313
-21% -$9.34K ﹤0.01% 873
2015
Q2 		$49K Buy
+1,513
New +$57.8K ﹤0.01% 1078
2015
Q1 		– Sell
-60,353
Closed -$1.37M – 1168
2014
Q4 		$1.37M Hold
60,353
– – 0.02% 475
2014
Q3 		$1.17M Buy
60,353
+347
+0.6% +$9.8K 0.02% 562
2014
Q2 		$2.18M Hold
60,006
– – 0.03% 394
2014
Q1 		$2.33M Sell
60,006
-141,082
-70% -$5.03M 0.04% 362
2013
Q4 		$5.73M Buy
+201,088
New +$5.9M 0.11% 181

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Visium Asset Management's RIGL Position: Q4 2015 in Review

Visium Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2015, closing a stake of 1,200 shares — an estimated $30K sold.

Visium Asset Management first reported a position in RIGL in Q4 2013 and held it in 7 quarters. The position peaked at $5.73M in Q4 2013. 121 funds tracked by Wall St. Rank hold RIGL as of Q4 2015.

  • Visium Asset Management reported no remaining Rigel Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Visium Asset Management sold 1,200 Rigel Pharmaceuticals shares in Q4 2015, an estimated $30K.
  • Visium Asset Management first reported a position in Rigel Pharmaceuticals in Q4 2013 and held it in 7 quarters.
  • Visium Asset Management's Rigel Pharmaceuticals position peaked at $5.73M in Q4 2013.
  • 121 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.